Annual Current Liabilities
$12.00 B
+$724.00 M+6.42%
December 31, 2024
Summary
- As of February 23, 2025, GILD annual total current liabilities is $12.00 billion, with the most recent change of +$724.00 million (+6.42%) on December 31, 2024.
- During the last 3 years, GILD annual current liabilities has risen by +$394.00 million (+3.39%).
- GILD annual current liabilities is now at all-time high.
Performance
GILD Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$12.00 B
+$280.00 M+2.39%
December 31, 2024
Summary
- As of February 23, 2025, GILD quarterly total current liabilities is $12.00 billion, with the most recent change of +$280.00 million (+2.39%) on December 31, 2024.
- Over the past year, GILD quarterly current liabilities has increased by +$280.00 million (+2.39%).
- GILD quarterly current liabilities is now -14.04% below its all-time high of $13.96 billion, reached on June 30, 2023.
Performance
GILD Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
GILD Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +6.4% | +2.4% |
| 3 y3 years | +3.4% | +2.4% |
| 5 y5 years | +23.0% | +2.4% |
GILD Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +6.8% | -14.0% | +40.3% |
| 5 y | 5-year | at high | +23.0% | -14.0% | +40.3% |
| alltime | all time | at high | >+9999.0% | -14.0% | >+9999.0% |
Gilead Sciences Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $12.00 B(+6.4%) | $12.00 B(+2.4%) |
| Sep 2024 | - | $11.72 B(+8.8%) |
| Jun 2024 | - | $10.78 B(-17.2%) |
| Mar 2024 | - | $13.02 B(+15.4%) |
| Dec 2023 | $11.28 B(+0.4%) | $11.28 B(-5.6%) |
| Sep 2023 | - | $11.95 B(-14.5%) |
| Jun 2023 | - | $13.96 B(+32.6%) |
| Mar 2023 | - | $10.53 B(-6.3%) |
| Dec 2022 | $11.24 B(-3.2%) | $11.24 B(+7.8%) |
| Sep 2022 | - | $10.42 B(+13.0%) |
| Jun 2022 | - | $9.22 B(+7.7%) |
| Mar 2022 | - | $8.56 B(-26.3%) |
| Dec 2021 | $11.61 B(+1.9%) | $11.61 B(+13.3%) |
| Sep 2021 | - | $10.24 B(+0.3%) |
| Jun 2021 | - | $10.21 B(+5.2%) |
| Mar 2021 | - | $9.71 B(-14.8%) |
| Dec 2020 | $11.40 B(+16.8%) | $11.40 B(+19.9%) |
| Sep 2020 | - | $9.51 B(-10.0%) |
| Jun 2020 | - | $10.56 B(+19.0%) |
| Mar 2020 | - | $8.88 B(-9.0%) |
| Dec 2019 | $9.76 B(-8.0%) | $9.76 B(+2.0%) |
| Sep 2019 | - | $9.57 B(+6.8%) |
| Jun 2019 | - | $8.96 B(-4.6%) |
| Mar 2019 | - | $9.40 B(-11.4%) |
| Dec 2018 | $10.61 B(-8.9%) | $10.61 B(+4.8%) |
| Sep 2018 | - | $10.12 B(-7.3%) |
| Jun 2018 | - | $10.91 B(+2.3%) |
| Mar 2018 | - | $10.67 B(-8.3%) |
| Dec 2017 | $11.63 B(+26.2%) | $11.63 B(+21.2%) |
| Sep 2017 | - | $9.60 B(+13.0%) |
| Jun 2017 | - | $8.49 B(+2.5%) |
| Mar 2017 | - | $8.28 B(-10.2%) |
| Dec 2016 | $9.22 B(-6.8%) | $9.22 B(-16.8%) |
| Sep 2016 | - | $11.07 B(+6.0%) |
| Jun 2016 | - | $10.44 B(-4.3%) |
| Mar 2016 | - | $10.91 B(+10.3%) |
| Dec 2015 | $9.89 B(+71.7%) | $9.89 B(+5.7%) |
| Sep 2015 | - | $9.36 B(+4.9%) |
| Jun 2015 | - | $8.93 B(+20.2%) |
| Mar 2015 | - | $7.43 B(+28.9%) |
| Dec 2014 | $5.76 B(-10.1%) | $5.76 B(-4.9%) |
| Sep 2014 | - | $6.05 B(-2.8%) |
| Jun 2014 | - | $6.23 B(+5.3%) |
| Mar 2014 | - | $5.91 B(-7.7%) |
| Dec 2013 | $6.41 B(+51.2%) | $6.41 B(+30.9%) |
| Sep 2013 | - | $4.90 B(-0.9%) |
| Jun 2013 | - | $4.94 B(+15.1%) |
| Mar 2013 | - | $4.29 B(+1.2%) |
| Dec 2012 | $4.24 B(+68.5%) | $4.24 B(-11.7%) |
| Sep 2012 | - | $4.80 B(-3.7%) |
| Jun 2012 | - | $4.99 B(+19.1%) |
| Mar 2012 | - | $4.19 B(+66.5%) |
| Dec 2011 | $2.51 B(+2.0%) | $2.51 B(+13.1%) |
| Sep 2011 | - | $2.22 B(-3.7%) |
| Jun 2011 | - | $2.31 B(-16.5%) |
| Mar 2011 | - | $2.77 B(+12.3%) |
| Dec 2010 | $2.46 B(+31.7%) | $2.46 B(-4.8%) |
| Sep 2010 | - | $2.59 B(-16.6%) |
| Jun 2010 | - | $3.11 B(+64.5%) |
| Mar 2010 | - | $1.89 B(+0.9%) |
| Dec 2009 | $1.87 B(+53.3%) | $1.87 B(-0.9%) |
| Sep 2009 | - | $1.89 B(+6.3%) |
| Jun 2009 | - | $1.78 B(+40.9%) |
| Mar 2009 | - | $1.26 B(+3.3%) |
| Dec 2008 | $1.22 B | $1.22 B(-3.0%) |
| Sep 2008 | - | $1.26 B(-48.6%) |
| Jun 2008 | - | $2.45 B(+161.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2008 | - | $939.00 M(+27.5%) |
| Dec 2007 | $736.27 M(-3.7%) | $736.27 M(+6.5%) |
| Sep 2007 | - | $691.44 M(-8.0%) |
| Jun 2007 | - | $751.73 M(+5.8%) |
| Mar 2007 | - | $710.49 M(-7.0%) |
| Dec 2006 | $764.28 M(+64.3%) | $764.28 M(+31.4%) |
| Sep 2006 | - | $581.83 M(+14.5%) |
| Jun 2006 | - | $507.97 M(+20.4%) |
| Mar 2006 | - | $421.90 M(-9.3%) |
| Dec 2005 | $465.16 M(+83.5%) | $465.16 M(+73.7%) |
| Sep 2005 | - | $267.87 M(+2.6%) |
| Jun 2005 | - | $261.19 M(-3.3%) |
| Mar 2005 | - | $270.22 M(+6.6%) |
| Dec 2004 | $253.45 M(+36.3%) | $253.45 M(+16.5%) |
| Sep 2004 | - | $217.53 M(+24.4%) |
| Jun 2004 | - | $174.83 M(-0.5%) |
| Mar 2004 | - | $175.79 M(-5.4%) |
| Dec 2003 | $185.90 M(+77.2%) | $185.90 M(+39.3%) |
| Sep 2003 | - | $133.40 M(-2.3%) |
| Jun 2003 | - | $136.59 M(+5.1%) |
| Mar 2003 | - | $130.01 M(+23.9%) |
| Dec 2002 | $104.89 M(+30.9%) | $104.89 M(+22.7%) |
| Sep 2002 | - | $85.48 M(+3.4%) |
| Jun 2002 | - | $82.69 M(+19.7%) |
| Mar 2002 | - | $69.08 M(-13.8%) |
| Dec 2001 | $80.12 M(+37.6%) | $80.12 M(+11.7%) |
| Sep 2001 | - | $71.74 M(+26.6%) |
| Jun 2001 | - | $56.69 M(+2.7%) |
| Mar 2001 | - | $55.20 M(-5.2%) |
| Dec 2000 | $58.24 M(+21.6%) | $58.24 M(+15.0%) |
| Sep 2000 | - | $50.63 M(+13.4%) |
| Jun 2000 | - | $44.63 M(+4.6%) |
| Mar 2000 | - | $42.67 M(-10.9%) |
| Dec 1999 | $47.88 M(-16.4%) | $47.88 M(-15.7%) |
| Sep 1999 | - | $56.80 M(+110.4%) |
| Jun 1999 | - | $27.00 M(-7.8%) |
| Mar 1999 | - | $29.30 M(-48.9%) |
| Dec 1998 | $57.30 M(+71.6%) | $57.30 M(+83.1%) |
| Sep 1998 | - | $31.30 M(-1.9%) |
| Jun 1998 | - | $31.90 M(-13.6%) |
| Mar 1998 | - | $36.90 M(+10.5%) |
| Dec 1997 | $33.40 M(+107.5%) | $33.40 M(+60.6%) |
| Sep 1997 | - | $20.80 M(-3.3%) |
| Jun 1997 | - | $21.50 M(-13.7%) |
| Mar 1997 | - | $24.90 M(+54.7%) |
| Dec 1996 | $16.10 M(+37.6%) | $16.10 M(0.0%) |
| Sep 1996 | - | $16.10 M(+10.3%) |
| Jun 1996 | - | $14.60 M(-2.7%) |
| Mar 1996 | - | $15.00 M(+36.4%) |
| Dec 1995 | $11.70 M(+7.3%) | - |
| Sep 1995 | - | $11.00 M(+14.6%) |
| Jun 1995 | - | $9.60 M(-11.9%) |
| Mar 1995 | - | $10.90 M(+4.8%) |
| Mar 1995 | $10.90 M(+23.9%) | - |
| Dec 1994 | - | $10.40 M(-2.8%) |
| Sep 1994 | - | $10.70 M(+33.8%) |
| Jun 1994 | - | $8.00 M(-9.1%) |
| Mar 1994 | $8.80 M(+39.7%) | $8.80 M(+12.8%) |
| Dec 1993 | - | $7.80 M(-4.9%) |
| Sep 1993 | - | $8.20 M(+64.0%) |
| Jun 1993 | - | $5.00 M(-20.6%) |
| Mar 1993 | $6.30 M(+162.5%) | $6.30 M(+26.0%) |
| Dec 1992 | - | $5.00 M(+11.1%) |
| Sep 1992 | - | $4.50 M(+150.0%) |
| Jun 1992 | - | $1.80 M(-25.0%) |
| Mar 1992 | $2.40 M(+33.3%) | $2.40 M(+33.3%) |
| Mar 1991 | $1.80 M | $1.80 M |
FAQ
- What is Gilead Sciences annual total current liabilities?
- What is the all time high annual current liabilities for Gilead Sciences?
- What is Gilead Sciences annual current liabilities year-on-year change?
- What is Gilead Sciences quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Gilead Sciences?
- What is Gilead Sciences quarterly current liabilities year-on-year change?
What is Gilead Sciences annual total current liabilities?
The current annual current liabilities of GILD is $12.00 B
What is the all time high annual current liabilities for Gilead Sciences?
Gilead Sciences all-time high annual total current liabilities is $12.00 B
What is Gilead Sciences annual current liabilities year-on-year change?
Over the past year, GILD annual total current liabilities has changed by +$724.00 M (+6.42%)
What is Gilead Sciences quarterly total current liabilities?
The current quarterly current liabilities of GILD is $12.00 B
What is the all time high quarterly current liabilities for Gilead Sciences?
Gilead Sciences all-time high quarterly total current liabilities is $13.96 B
What is Gilead Sciences quarterly current liabilities year-on-year change?
Over the past year, GILD quarterly total current liabilities has changed by +$280.00 M (+2.39%)